Updated Results of the COVID-19 in MS Global Data Sharing Initiative: Anti-CD20 and Other Risk Factors Associated With COVID-19 Severity.

Neurol Neuroimmunol Neuroinflamm · 2022 · PMC9423711 · PMID 36038263

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

12 In addition, although in our present analysis, ocrelizumab shows a positive trend with the need for artificial ventilation, rituximab shows consistent associations with COVID-19 outcomes, including death.

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.